|
|
Interrupting the Cycle of Cardiovascular-Renal-Metabolic (CVRM) Disease: Strategies for Adapting Practice to Evolving Guidelines
|
|
Facebook
LinkedIn
E-Mail
|
(6818)
|
Released: 11/13/2024
Expires: 11/30/2025 (subject to change)
- CE for this activity will not be available after this date.
 | This activity includes closed captioning. |
| Delivery Note: The content for this activity was previously presented during the 2024 AANP Fall Conference. If you already completed the content of this activity while attending the live conference, you should not complete this content a second time. Learners should only complete ONE delivery-method to earn credit. Completing multiple delivery options for the same activity is considered duplicate credit for the same content and will not be accepted by regulatory bodies. |
Overview
Cardiovascular-Renal-Metabolic (CVRM) Diseases - also known as cardio-kidney-metabolic (CKM) syndrome - encompasses a constellation of conditions including cardiovascular disease (CVD), chronic kidney disease, and metabolic disorders such as diabetes and obesity which, combined, are the leading cause of death worldwide. This activity is designed to aid NPs who are pivotal members of the healthcare team to understand the pathophysiologic interplay of cardiovascular-renal-metabolic diseases, adopt guideline-driven strategies to mitigate risk and thoughtfully select therapies known to decrease the burden of disease across the CVRM spectrum, recognize ways in which social determinants of health (SDOH) impacts barriers to optimal CVRM care and identify ways in which new data and evidence-based approaches to comprehensive CVRM care may be swiftly integrated into individual practice.
Objectives - Implement evidence-driven and guideline-concordant strategies for recognizing and managing cardiometabolic disease manifestations.
- Evaluate cardiometabolic disease risk for individual patients using current assessment tools and methodologies.
- Address social determinants of health (SDOH) contributing to disparate cardiometabolic clinical outcomes and fragmented care.
- Utilize new strategies for a multidisciplinary approach to comprehensive cardiometabolic care, fostering collaboration among cardiology, nephrology, and diabetes specialists, emphasizing shared decision-making.
Speakers
Debbie Hinnen, APN, BC-ADM, FAAN, FADCES
Carrie Palmer, DNP, RN, ANP-BC, CDE
Disclosure
This program was planned in accordance with AANP CE Standards and Policies.The speakers have the following disclosures:
- Debbie Hinnen
- I am a speaker for Lilly, Novo, Sanofi, Intuity and Theracos Bio company for Diabetes disease process/clinical area.
- I am on the advisory board for Novo company for Diabetes disease process/clinical area.
- All relevant financial relationships have been mitigated.
- Carrie Palmer
All Planners involved in this activity have no relevant financial relationships to disclose.
This presentation was first presented as a live event at AANP's 2024 Fall Conference in Reno, NV.
Disclaimer
Individuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
CE Credit Instructions- Read this activity description, including objectives and disclosures.
- Complete the educational content:
- Video Presentations: Click the Play button to watch the activity presentation. Full participation credit for the activity will be received once the entire video has been watched.
- Click on the Additional Resources button to review all additional materials provided (handouts, post-test reviews, any other downloadable resources).
- After completing all content, click on the blue Next Steps button:
- Submit the evaluation to receive full AANP CE/Rx credit.
Additional Information
For questions or more information concerning this online CE activity, please visit the AANP Help Center to find answers to frequently asked questions and request assistance.
1 Contact Hour(s) of CE,
All of which may be applied towards Pharmacology
|
|
Additional CE activities of interest
(OnDemand)
Advanced Pharmacology And Treatments In HTN
(OnDemand)
Compassionate Care in Pain Management and Substance Use Disorder
(OnDemand)
Optimizing Pharmacotherapy for Dyslipidemia in Women: Tailored Approaches and Clinical Considerations
(OnDemand)
Peripheral Arterial Disease
(OnDemand)
Medications Used In Pulmonary Hypertension
(OnDemand)
Current Therapeutics For Cardiac Amyloidosis
(OnDemand)
Key Elements in the Management and Treatment of Schizophrenia
(Accredited Podcast)
Four Pillars of Medications for Heart Failure with Reduced Ejection Fraction (HFrEF)
(OnDemand)
Understanding Autoimmune Thyroid Testing
(OnDemand)
Hyperparathyroidism Current Treatment Guidelines
(OnDemand)
Navigating Menopause: Understanding Pharmacological Interventions
(OnDemand)
Non-Opioid Pharmacology and Integrative Health Solutions for Chronic Pain
|
|
Adding Registration, Please wait...
